You are currently viewing LIVE FROM THE MARKETS: Stellantis, EssilorLuxottica, Valeo, Roche Bobois, Inditex, Apple, Fosun…

LIVE FROM THE MARKETS: Stellantis, EssilorLuxottica, Valeo, Roche Bobois, Inditex, Apple, Fosun…

  • Post category:Economy News
  • Reading time:5 mins read

Chief Editor


follow on

Because financial information is consumed like pastries, hot and at breakfast time, Anthony Bondain gets up at dawn to serve you the Morning Meeting every morning.
A financial journalist and stockbroker for more than two decades, an inimitable editorialist and phlegmatic leader, he is editor-in-chief of ZoneBourse.

Every morning, the Zonebourse team collects and summarizes key information concerning listed companies around the world, to have access to the main news at the start of the stock market day. The content includes a section on France and the other on the main international markets, in particular American companies and those in large European markets (UK, Germany, Switzerland, Italy, Spain) and Asia-Pacific.

In France

Important (and less important) announcements

  • Stellantis will devote €923 million to buying back the shares issued to General Motors during the takeover of Opel and will give the American €130 million and Faurecia shares.
  • Capgemini launches a new employee share ownership plan.
  • EssilorLuxottica renews its license agreement with Armani.
  • Arkema is launching a new employee shareholding plan.
  • Valeo and the CEA are collaborating in power electronics.
  • Gaztransport & Technigaz signs an order with Hyundai Samho Heavy Industries for the design of the tanks of two LNG carriers.
  • Uniti launches the construction of a real estate complex in Sète.
  • Auplata will repay €5.5 million in current account debt to TNRF with a reserved capital increase, before issuing €2 million in ORNANE.
  • Sensorion announces the enrollment of the first patient in the proof-of-concept clinical trial of SENS-401 for the preservation of residual hearing during cochlear implantation.
  • The FDA granted orphan drug status to Genfit’s GNS561 in cholangiocarcinoma, which should enter phase II at the end of the year.
  • Herige, Roche Bobois, Les Constructeurs du Bois, Antin Infrastructure Partners, Onxeo, BOA Concept, Groupe Crit, Clasquin, CBo Territoria, Groupe Partouche, Fleury Michon have published their accounts.

In the world

Important (and less important) announcements

  • Inditex posted sharply higher sales, but the slowdown is looming.
  • Apple plans to use Taiwan Semiconductor’s latest chip technology in iPhones and Macs.
  • Twitter shareholders approve takeover by Musk, who no longer wants to take over.
  • The Norwegian sovereign wealth fund is eyeing a stake in Porsche during the IPO.
  • Fosun International plummeted after news emerged that Chinese regulators have urged the country’s big banks to assess their exposure to the conglomerate that owns Club Med. Society deems the information absurd.
  • Redrow points out that demand is moderating in the UK housing market.
  • South Korea fines Google and Meta Platforms for violating privacy law.
  • Honda is considering listing its electric motorcycle branch, according to the WSJ.
  • AB Volvo begins mass production of heavy-duty electric trucks.
  • Lalique takes over the Zurich silk label Fabric Frontline.
  • Ferrari is courting the super-rich with a $390,000 gas-powered SUV, but that’s not to say it’s an SUV.
  • Main publications of the day: Inditex, BRP Inc, Manchester United, Redrow, ITM Power, S4 Capital… The whole agenda here.

Readings 2022